Clinical Trials Logo

Filter by:
NCT ID: NCT05111223 Completed - Healthy Clinical Trials

Testing the Contribution of Orbitofrontal Cortex Networks to Decision-making

Start date: June 16, 2021
Phase: N/A
Study type: Interventional

This research study examines the contribution of orbitofrontal cortex (OFC) networks to decision-making.

NCT ID: NCT05111041 Completed - Clinical trials for Smokeless Tobacco Cessation

Smokeless Tobacco Cessation Intervention for Firefighters

Start date: January 25, 2022
Phase: N/A
Study type: Interventional

The investigators are asking professional firefighters across North Carolina to take part in focus groups to discuss the specific needs of firefighters in smokeless tobacco cessation. About 40 firefighters will take part in the focus groups. The purpose of the focus groups is to learn how firefighting and shift work impact smokeless tobacco use and risk perceptions related to chew or dip. Using their feedback, the study team will then develop a cessation program specifically geared towards firefighters and first responders. The cessation program will be a mobile text / chat intervention specifically tailored to needs of firefighters and first responders who wish to stop using smokeless tobacco. About 50 firefighters and first responders will take part in this program, while being randomized into either the intervention group or the control group.

NCT ID: NCT05110976 Completed - Asthma Clinical Trials

A Study to Investigate the Safety, Tolerability and Effects of AZD8630 in Healthy Subjects and Subjects With Asthma on Inhaled Corticosteroids and Long-acting Beta-agonists

Start date: December 16, 2021
Phase: Phase 1
Study type: Interventional

This is a first in human (FIH) clinical study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of AZD8630 in healthy adults (Part A) and adult asthma patients on medium to high dose inhaled corticosteroids / Long-acting beta-agonists (Part B)

NCT ID: NCT05110872 Completed - Clinical trials for Tobacco Use Disorder

Cigarette and E-cigarette Flavors Manipulations in the Experimental Tobacco Marketplace

Start date: July 26, 2021
Phase: N/A
Study type: Interventional

This is a one-session study that participants complete remotely including consent, Experimental Tobacco Marketplace purchases, and assessments to examine the effects of cigarette and e-cigarette flavors on cigarette demand and substitution in the Experimental Tobacco Marketplace.

NCT ID: NCT05110716 Completed - Cigarette Smoking Clinical Trials

Effects of Choice Bundling on Valuation of Delayed Gains and Losses in Cigarette Smokers

Start date: July 26, 2021
Phase: N/A
Study type: Interventional

The present study will investigate the effects of choice bundling, in which a single choice produces a series of repeating consequences, on valuation of delayed monetary gains and losses in an online panel of cigarette smokers.

NCT ID: NCT05110703 Completed - Clinical trials for Diabetes Mellitus, Type 2

Study to Assess Safety and Effect of a Prebiotic Fiber Meal Replacement Shake in Individuals With Type 2 Diabetes

Start date: October 11, 2021
Phase: N/A
Study type: Interventional

This study is a double-blind, randomized, trial of a commercially available meal-replacement shake versus a placebo control designed to evaluate the impact on quality of life, safety, and tolerability. It also includes a randomized, non-blinded third arm consisting of only dietary guidelines.

NCT ID: NCT05110690 Completed - Depression Clinical Trials

Behavioral Activation and Medication Optimization for Perioperative Mental Health Feasibility Study

Start date: November 17, 2021
Phase: N/A
Study type: Interventional

Inadequate management of preoperative mental health disorders often contributes to poor postoperative outcomes, including increased rates of readmission, delirium, falls, and mortality. However, very little work has been done to improve perioperative mental health. In particular, there have been limited systematic efforts that identify evidence-based behavioral and pharmacological strategies that were originally developed for depression and anxiety in otherwise medically well psychiatric patients. A mental health intervention bundle, composed of behavioral and pharmacological strategies, can mitigate anxiety and depression symptoms during the perioperative period. However, lacking is conclusive evidence on effectiveness of such an intervention bundle focused on the delivery of perioperative mental health care in older surgical patients. Towards this end, the investigators will develop and test an intervention bundle that encompasses: (1) behavioral activation, and (2) medication optimization.

NCT ID: NCT05110508 Completed - Physical Activity Clinical Trials

Active KC: a Text Message Based Intervention for Physical Activity

Start date: September 25, 2021
Phase: N/A
Study type: Interventional

Active KC will involve delivering PA support tools to individuals interested in increasing their physical activity. The tools involve provision of a Garmin wearable activity monitor and participant-tailored behavior change supports (e.g., goal setting and monitoring) delivered through text messaging and a corresponding study website.

NCT ID: NCT05110274 Completed - Metabolism Clinical Trials

Validating a Novel Approach to Assess Metabolic Flexibility in a Respiratory Chamber

METFLEX II
Start date: August 26, 2021
Phase: N/A
Study type: Interventional

This study is designed to test the reliability of a novel procedure for measuring metabolic flexibility, i.e., the ability to quickly adapt macronutrient oxidation to macronutrient availability, in a respiratory chamber. The investigators will compare paired measurements of metabolic flexibility determined 5-7 days apart in a metabolic chamber to assess reliability. The investigators will also compare their novel method of measuring metabolic flexibility in a respiratory chamber with a more convention method, metabolic flexibility during a hyperinsulinemic clamp.

NCT ID: NCT05110209 Completed - Clinical trials for Age-related Macular Degeneration (AMD)

Real-world Evaluation of Prevalence of Ocular Adverse Events in Patients With Neovascular (Wet) Agerelated Macular Degeneration (AMD) Who Received Anti-VEGF Agents (IRIS Registry)

Start date: July 15, 2020
Phase:
Study type: Observational

In this cross-sectional study of patients with wet AMD who received ≥1 anti-VEGF injection (excluding brolucizumab), evidence was generated to describe the period prevalence of specific ocular AEs. The study was conducted using the IRIS Registry, and all results were based on the study period from 01/01/2019 to 12/31/2019.